Showing 5351-5360 of 6036 results for "".
- Small Business Rescue Loan Program Is Now Out of Moneyhttps://modernod.com/news/small-business-rescue-loan-program-is-now-out-of-money/2477598/The Small Business Administration’s rescue loan program hit its $349 billion limit on Thursday and is now out of money as the nation’s top Republicans and Democrats struggle to agree on how to restore its funds, according to a CNBC
- HealthVerity Patient Confidence Index Aims to Become Bellwether Measure of Impact to Non-COVID-19 Patients and Physicianshttps://modernod.com/news/healthverity-patient-confidence-index-aims-to-become-bellwether-measure-of-impact-to-non-covid-19-patients-and-physicians/2477590/HealthVerity, a provider of privacy-protected data exchange for pharmaceutical manufacturers and insurers, announced the launch of the HealthVerity Patient Confidence Index, or HVPCI, and reported the first national benchmark score of 68. Indexed against a pre-pandemic score of 100, this level is
- AstraZeneca to Study BTK Inhibitor Calquence as Treatment for Cytokine Storm Associated With COVID-19 Infectionhttps://modernod.com/news/astrazeneca-to-study-btk-inhibitor-calquence-as-treatment-for-cytokine-storm-associated-with-covid-19-infection/2477575/AstraZeneca announced that it will investigate the potential of the BTK inhibitor Calquence (acalabrutinib) in the treatment of the cytokine storm associated with COVID-19 infection in severely ill patients. The company noted that the design of the CALAVI study is based on “strong scientifi
- Telehealth’s Not Getting Switched Off After COVID-19 Crisishttps://modernod.com/news/telehealths-not-getting-switched-off-after-covid-19-crisis/2477566/The coronavirus pandemic has forced the federal government to lift barriers to telemedicine so patients can get care without leaving home. Those regulatory changes may be temporary, but experts say telehealth is here to stay, according to a Law 360
- CMS Relaxes Rules to Boost Capacity of Providers as Facilities Tackle COVID-19 Outbreakhttps://modernod.com/news/cms-relaxes-rules-to-boost-capacity-of-providers-as-facilities-tackle-covid-19-outbreak/2477562/The Trump administration has relaxed rules to enable doctors to remotely care for patients across state lines at rural facilities and let nurse practitioners perform more duties as workforce capacity becomes a major concern, according to a FierceHealthcare
- Vazegepant, Investigational Drug Being Studied for Migraine, to Enter Phase 2 Trial for COVID-19 Treatmenthttps://modernod.com/news/vazegepant-investigational-drug-being-studied-for-migraine-to-enter-phase-2-trial-for-covid-19-treatment/2477557/The FDA has authorized initiation of a phase 2 trial of vazegepant (Biohaven, New Haven, CT) for potential treatment of COVID-19 pulmonary complications. Vazegepant is an intranasally delivered calcitonin gene-related peptide (CGRP) inhibitor antagonist in phase 3 trials for the treatment of migr
- Clearside Biomedical Establishes Scientific Advisory Board with Distinguished Retinal Physicianshttps://modernod.com/news/clearside-biomedical-establishes-scientific-advisory-board-with-distinguished-retinal-physicians/2477553/Clearside Biomedical announced the formation of a Scientific Advisory Board comprised of world-renowned retinal physicians to advise on the company’s research and development programs. “Over the past year, we have been building awareness around the potentia
- CMS Has Doled Out Nearly $34B in Advance, Accelerated Payments to Providers to Combat COVID-19https://modernod.com/news/cms-has-doled-out-nearly-34b-in-advance-accelerated-payments-to-providers-to-combat-covid-19/2477550/The Trump administration delivered nearly $34 billion in advance and accelerated payments to providers over the past week as more and more health systems furlough worker
- Nicox Outlines Plans to Progress NCX 4251 into Phase 2b Trial Following Positive Meeting with FDAhttps://modernod.com/news/nicox-outlines-plans-to-progress-ncx-4251-into-phase-2b-trial-following-positive-meeting-with-fda/2477548/Nicox SA announced that it has held a Type C meeting with the FDA in which the data from the recently completed Danube phase 2 clinical trial of NCX 4251 was reviewed and the next NCX 4251 trial designs were discussed. Given the positive Danube phase 2 trial results in reduction of the signs and
- Icare USA Completes Merger with CenterVuehttps://modernod.com/news/icare-usa-completes-merger-with-centervue/2477549/Icare USA announced that it has completed its merger with CenterVue after the acquisition of CenterVue by Revenio Group Corporation in April 2019. Financial terms of the deal were not disclosed. In March 2020, the two corporations were consolidated under a single management team. Co